Industry sponsor

Resilient Pharmaceuticals

30 registered trials on this registry. An industry sponsor is running trials with a view to approval and sale.

Registered trials

Recruiting

In Phase 3

With results posted

Working on

Substances

MDMA30

Trials

All 30 trials

Trial	Status	Phase	Substance	Sites
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)NCT03537014 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	15
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)NCT04077437 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	14
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDNCT04714359 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	15
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSDNCT04784143 · Resilient Pharmaceuticals	Terminated	Phase 2	mdma	1
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)NCT03485287 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	2
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress DisorderNCT00090064 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSDNCT01689740 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - IsraelNCT00402298 · Resilient Pharmaceuticals	Terminated	Phase 2	mdma	1
Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress DisorderNCT01211405 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSDNCT01793610 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSDNCT01958593 · Resilient Pharmaceuticals	Terminated	Phase 2	mdma	1
Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic AdultsNCT02008396 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening IllnessNCT02427568 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDNCT03282123 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	12
MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSDNCT02876172 · Resilient Pharmaceuticals	Completed	Phase 1 / Phase 2	mdma	1
Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDNCT04968938 · Resilient Pharmaceuticals	Withdrawn	Phase 2	mdma	—
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating DisordersNCT04454684 · Resilient Pharmaceuticals	Withdrawn	Phase 2	mdma	—
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in VeteransNCT05173831 · Resilient Pharmaceuticals	Withdrawn	Phase 2	mdma	—
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress DisorderNCT00353938 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy TrialNCT01458327 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Study of Midomafetamine in Healthy AdultsNCT07584720 · Resilient Pharmaceuticals	Active, not recruiting	Phase 1	mdma	1
Evaluation of MDMA on Startle ResponseNCT03181763 · Resilient Pharmaceuticals	Completed	Phase 1	mdma	1
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersNCT01404754 · Resilient Pharmaceuticals	Completed	Phase 1	mdma	3
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)NCT04073433 · Resilient Pharmaceuticals	Withdrawn	Phase 1	mdma	—
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic FunctionNCT03606538 · Resilient Pharmaceuticals	Not yet recruiting	Phase 1	mdma	1
Food Effects on Bioavailability of MDMA in Healthy VolunteersNCT05147402 · Resilient Pharmaceuticals	Completed	Phase 1	mdma	1
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSDNCT02102802 · Resilient Pharmaceuticals	Completed	N/A	mdma	1
Correlates of Anxiety Associated With a Life-threatening IllnessNCT02954562 · Resilient Pharmaceuticals	Completed	N/A	mdma	1
A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSDNCT04438512 · Resilient Pharmaceuticals	No longer available	N/A	mdma	2
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSDNCT05066282 · Resilient Pharmaceuticals	Completed	N/A	mdma	4

Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.